Company Filing History:
Years Active: 2022-2025
Title: Innovations of Haihui Lu in Cancer Treatment
Introduction
Haihui Lu is a prominent inventor based in Cambridge, MA, known for his significant contributions to the field of cancer treatment. He holds a total of 3 patents that focus on binding molecules aimed at targeting specific cancer markers. His work is instrumental in developing therapies that can potentially improve patient outcomes in oncology.
Latest Patents
One of Haihui Lu's latest patents is titled "Binding molecules against BCMA and uses thereof." This patent provides BCMA binding molecules that specifically bind to human BCMA, along with conjugates and pharmaceutical compositions that utilize these binding molecules. The patent also outlines methods for using these molecules to treat cancers that express cell surface BCMA. Additionally, it describes recombinant host cells engineered to express the BCMA binding molecules and methods for producing them through cell culture.
Another significant patent is "CD19 binding molecules and uses thereof." This patent details CD19 binding molecules that specifically bind to CD19, including various forms such as monospecific, bispecific, and trispecific binding molecules. It also includes conjugates and pharmaceutical compositions that incorporate these binding molecules. The patent further elaborates on methods for using CD19 binding molecules to treat diseases associated with CD19 expression, as well as the engineering of recombinant host cells for their production.
Career Highlights
Haihui Lu is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis focuses on advancing innovative therapies that target specific cancer markers, contributing to the development of cutting-edge treatments in the pharmaceutical industry.
Collaborations
Haihui Lu collaborates with talented professionals in his field, including Connie Hong and Aida Abujoub. These collaborations enhance the research and development efforts aimed at creating effective cancer therapies.
Conclusion
Haihui Lu's innovative work in developing binding molecules for cancer treatment showcases his commitment to advancing medical science. His patents represent significant strides in targeted therapies, which hold promise for improving cancer treatment outcomes.